| A Case of Cutaneous Sarcoidosis Associated with Pegylated Interferon Alpha-2a and Ribavirin Therapy |
|
Ki Hyun Kwon, Dong Cheon Ha, Jeong Hwa Lee, Tae Youn Heo, Young Yong Ahn, Yeon Soo Kim, Dong Soo Lee |
|
|
| 페그인터페론과 리바비린 병합요법 중 발생한 피부 유육종증 1예 |
|
권기현, 하동천, 이정화, 허태윤, 안영용, 김연수, 이동수 |
|
|
|
|
|
|
| Abstract |
|
Pegylated interferon plus ribavirin is the standard treatment regimen in chronic hepatitis C. The main adverse events of pegylated interferon plus ribavirin combination therapy are bone marrow depression, alopecia, insomnia, and influenza-like symptoms. However, there are few reports of cutaneous sarcoidosis occurring during pegylated interferon alpha-2a and ribavirin therapy. Here, we report a case of cutaneous sarcoidosis induced by pegylated interferon alpha-2a and ribavirin during the treatment for chronic hepatitis C. The patient’s sarcoidosis improved spontaneously after the treatment. |
| Key Words:
Hepatitis C; Pegylated interferon alpha-2a; Sarcoidosis |
|
PDF Links
PubReader
XML Download
Full text via DOI
Download Citation
